logo
  • Home
  • News
Menu

As Biology Manufacturing Company Zymergen Implodes, Correspondence With SEC Showed Early Doubts

Home / Stock Analysis / As Biology Manufacturing Company Zymergen Implodes, Correspondence With SEC Showed Early Doubts
Article feature image

As Biology Manufacturing Company Zymergen Implodes, Correspondence With SEC Showed Early Doubts

04 Aug Stock Analysis

Zymergen cofounder Josh Hoffman has stepped down as CEO, effective immediately.
CLINTON PERRY PHOTOGRAPHY 2019
On Tuesday afternoon, synthetic biology manufacturing company Zymergen said its cofounder and CEO would be stepping down immediately and that…

Click here to view the original article.

Tags:
Forbes, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

aviation_e9e02f.jpg
+

Turkey-based Çelebi’s stock price crashes nearly 20% in 2 days; company says will pursue ‘administrative and legal remedies’ to reverse India’s decision | Business News

16 May Stock Analysis
153cf4b4787999bbd9163aa9970e5ac6.jpeg
+

Analysis-US stock market gains may slow after torrid rebound from tariff swoon

16 May Stock Analysis

recent post

  • bic_Tether-covers_neutral_3_USDT.png.webp.webp

    USDT Signals Suggest the Bull Run

    May 16 2025
  • sec-securities-exchange-commission.jpg

    Chainlink praises SEC’s guidelines, setting stage

    May 16 2025
  • aviation_e9e02f.jpg

    Turkey-based Çelebi’s stock price crashes nearly

    May 16 2025
  • b3c35f59b015256a_400x400ar.png

    Launch your Crypto Casino with Slotegrator

    May 16 2025
  • 153cf4b4787999bbd9163aa9970e5ac6.jpeg

    Analysis-US stock market gains may slow

    May 16 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.